E22 vs N62
E22 (Hyperfunction of pituitary gland) compared with N62 (Hypertrophy of breast), from the official CMS tabular data. Do not report these codes together: the official tabular list marks them Excludes1.
Can these codes be reported together?
No — do not report together. E22 carries an Excludes1 note covering N62: “gynecomastia (N62)”
Sole exception: when the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).
Side by side
| E22Hyperfunction of pituitary gland | N62Hypertrophy of breast | |
|---|---|---|
| Billing status | Non-billable header | Billable |
| Classification | E00-E89 — Endocrine, Nutritional and Metabolic Diseases (E00-E89) | N00-N99 — Diseases of the Genitourinary System (N00-N99) |
| Definition | Hyperfunction of pituitary gland is a non-billable ICD-10-CM category code (E22). | Hypertrophy of breast is a billable ICD-10-CM diagnosis code (N62). |
| Includes | — | Gynecomastia Hypertrophy of breast NOS Massive pubertal hypertrophy of breast |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources